Clinical improvement in psoriasis during dithranol/UVB therapy does not correspond with a decrease in elevated serum soluble ICAM-1 levels

Arch Dermatol Res. 1993;285(4):233-5. doi: 10.1007/BF00372016.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Anthralin / immunology
  • Anthralin / therapeutic use*
  • Antigens, CD / blood*
  • Cell Adhesion Molecules / blood*
  • Combined Modality Therapy
  • Humans
  • Intercellular Adhesion Molecule-1
  • Male
  • Middle Aged
  • Psoriasis / therapy*
  • Solubility
  • Ultraviolet Therapy*

Substances

  • Antigens, CD
  • Cell Adhesion Molecules
  • Intercellular Adhesion Molecule-1
  • Anthralin